BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3

• Press Releases

  Alto Neuroscience Highlights Peer-Reviewed Publication of PAX-D Study in The Lancet Psychiatry Demonstrating Robust Clinical Effects of Pramipexole for Patients with Treatment-Resistant Depression

  July 1, 2025

   · 

  6 min read
• Press Releases

  Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs

  July 1, 2025

   · 

  2 min read
• Press Releases

  Revolution Medicines and Summit Therapeutics Enter Into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors With Ivonescimab in RAS Mutant Tumors

  July 1, 2025

   · 

  13 min read
• Press Releases

  AvenCell Awarded Up to $40 Million AMED Grant to Advance Allogeneic CAR-T Program

  July 1, 2025

   · 

  2 min read
• Press Releases

  DUBRETON CALLS FOR MANDATORY LABELING OF GENE-EDITED PORK IN NORTH AMERICA

  July 1, 2025

   · 

  2 min read
• Press Releases

  Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

  July 1, 2025

   · 

  6 min read
• Press Releases

  AN2 Therapeutics Reports Key Insights from 200-Patient Observational Study in Acute Melioidosis, Laying Groundwork for Phase 2 Proof-of-Concept Trial of Epetraborole

  July 1, 2025

   · 

  6 min read
• Press Releases

  OS Therapies Presents Statistically Significantly Positive 1-Year Event Free Survival, Overall Survival and Safety Clinical Data Updates for OST-HER2 at the MIB Agents Factor Osteosarcoma Conference

  July 1, 2025

   · 

  9 min read
• Press Releases

  Assembly Biosciences Doses First Participant in Phase 1b Portion of Phase 1a/b Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor ABI-1179

  July 1, 2025

   · 

  7 min read
• Press Releases

  Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

  July 1, 2025

   · 

  7 min read